Vertex Flooring introduces distinctive marquetry flooring crafted with expert precision, offering custom wood designs ...

If you are wondering whether Vertex Pharmaceuticals' current share price reflects its long term potential, a useful starting ...

AHD Clinic is a hair transplant center based in Antalya, a coastal city in southern Turkey. Company and media records state ...

The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source([1]) . The FDA approved three ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

Researchers from the High Energy Nuclear Physics Laboratory at the RIKEN Pioneering Research Institute (PRI) in Japan and their international collaborators have made a discovery that bridges ...

Abstract: As an alternative or complementary approach to the classical probability theory, the ability of the evidence theory in uncertainty quantification (UQ) analyses is subject of intense research ...

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...

With the business potentially at an important milestone, we thought we'd take a closer look at Vertex, Inc.'s (NASDAQ:VERX) future prospects. Vertex, Inc., together with its subsidiaries, provides ...

Aug 4 (Reuters) - Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage trial failure and will not start a study for expanded use of ...

Boston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR Therapeutics to develop the first CRISPR treatment approved by the U.S.